Navigation Links
NIH funds research center for women's reproductive health at Einstein
Date:3/20/2009

March 20, 2009 (BRONX, NY) The National Institute of Child Health and Development (NICHD) of the National Institutes of Health has awarded Albert Einstein College of Medicine of Yeshiva University a $7.5 million grant to establish a Specialized Cooperative Center Program in Reproduction and Infertility Research (SCCPIR).One of only 13 such centers in the country and the only one in New York State, the new center will focus on a wide range of diseases of the female reproductive tract, including menstrual disorders, endometriosis, and infertility.

"The grant will allow us to launch new studies of reproductive biology and to position Einstein as the focus of such studies for the entire state," says Jeffrey W. Pollard, Ph.D., professor of developmental and molecular biology and of obstetrics & gynecology and women's health, who will be leading the new center.

Created in 1997, the SCCPIR program promotes interactions among basic and clinical scientists. The goal is to translate breakthroughs in fundamental understanding of key reproductive processes into clinical practice, and promptly address in the laboratory questions that arise in the clinic. The centers also serve as national resources for training and developing the careers of new scientists who choose to pursue research in high priority areas of reproduction and infertility research.

Einstein's SCCPIR will concentrate on basic studies of endometrial biology and reproductive neuroendocrinology, with a particular emphasis on the reproductive health needs of the local Bronx community. (A complete list of the studies appears below.) "Research in reproductive biology has profoundly and positively influenced women's health in the last few decades," says Dr. Pollard. "More recently, the new technologies have enabled us to make great strides in understanding the basic biology of fertility and reproduction in animal models. This funding will help us determine whether the same biochemical pathways that we've identified in rodents are also operative in humans and then apply those findings to clinical practice."

"Our studies will have implications for the health of women in general. But we are particularly concerned with reproductive health in the Bronx, and this center will continue a profound partnership between Einstein and Montefiore Medical Center, The University Hospital and Academic Medical Center for Einstein," adds Dr. Pollard. "Obesity, diabetes, and metabolic syndrome are especially common here in the local community. Each of these conditions is strongly associated with reproductive tract diseases particularly infertility, endometriosis, and endometrial cancer."

Endometriosis, the abnormal growth of endometrial tissue outside the uterus, is one of the most common gynecological diseases, affecting more than 5.5 million women in North America. According to the NICHD, an estimated 2 to 10 percent of women of reproductive age have endometriosis. The two most common symptoms of the disease are pain and infertility. About 30 to 40 percent of women with endometriosis are infertile. In 2008, 40,100 women in the U.S. were diagnosed with endometrial cancer, another disease of abnormal cell growth in the endometrium, and 7,470 died of the disease, according to the National Cancer Institute.

"We are delighted to establish a SCCPIR at Einstein," adds Nanette Santoro, M.D., professor of obstetrics & gynecology and women's health. "The grant is highly competitive and this was the last year in which new sites could be added. In addition to having funds for our own research, the grant allows us to interact with the other SCCPIR sites nationwide and conduct collaborative studies relevant to our areas of interest."

Research Projects and Principal Investigators at Einstein's Specialized Cooperative Center Program in Reproduction and Infertility Research

  • "Estrogen and Progesterone Regulation of Human Endometrial Cell Proliferation"Drs. Pollard and Santoro.
  • "Reproductive Hormonal Alterations in Obesity"Dr. Santoro, Maureen Charron, Ph.D., professor of biochemistry, of obstetrics & gynecology and women's health, and of medicine; and Alex Polotsky, M.D., assistant professor of obstetrics & gynecology and women's health.
  • "IGF-I and Neuroendocrine Regulation of Female Reproductive Function"Anne Etgen, Ph.D., professor of neuroscience, of psychiatry and behavioral sciences, and of pediatrics; and Genevieve Neal-Perry, M.D., Ph.D., assistant professor of obstetrics & gynecology and women's health and of neuroscience.
  • "Antagonistic actions of melanocortins and leptin on reproductive competence"Streamson Chua, Jr., M.D., Ph.D., professor of medicine and of neuroscience.


'/>"/>

Contact: Deirdre Branley
dbranley@aecom.yu.edu
718-430-2923
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism
2. F-MARC funds more soccer and health research
3. More freedom to take risks: DFG funds the first Reinhart Koselleck Projects
4. NIH funds 16 Science Education Partnership Awards
5. NSF funds research at Illinois on sustainable biofuels infrastructure
6. NIAID funds studies of how SARS and bird flu evade antiviral responses
7. Human Microbiome Project awards funds for technology development, data analysis and ethical research
8. NSF funds new Center for the Physics of Living Cells at Illinois
9. NSF funds multi-university center to study environmental implications of nanotechnology
10. NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells
11. EPA funds ground-breaking Lyme disease research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... ... 2017 , ... The American Medical Informatics Association (AMIA) today ... Policy. Specifically, the nation’s leading informatics experts, said data sharing plans should be ... recommended that NIH earmark funding for researchers to produce and execute data sharing ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a ... The tremendous growth is accounted to two main factors. The first is ... expanding network of vendors supplying FireflySci products all around the world. , 2016 was ...
(Date:1/19/2017)... , Jan. 18, 2017 The ... reach USD 92.9 billion by 2025, according to ... Pharmaceutical industry has been adaptive of the function ... early as 2002. Among the services outsourced, clinical ... For instance, Johnson & Johnson was the first ...
Breaking Biology Technology: